Finn Bo Petersen

10.2k total citations · 1 hit paper
72 papers, 5.2k citations indexed

About

Finn Bo Petersen is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Finn Bo Petersen has authored 72 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hematology, 26 papers in Oncology and 13 papers in Epidemiology. Recurrent topics in Finn Bo Petersen's work include Hematopoietic Stem Cell Transplantation (47 papers), Acute Myeloid Leukemia Research (13 papers) and Polyomavirus and related diseases (12 papers). Finn Bo Petersen is often cited by papers focused on Hematopoietic Stem Cell Transplantation (47 papers), Acute Myeloid Leukemia Research (13 papers) and Polyomavirus and related diseases (12 papers). Finn Bo Petersen collaborates with scholars based in United States, South Africa and Germany. Finn Bo Petersen's co-authors include CD Buckner, F R Appelbaum, E. Donnall Thomas, Lloyd D. Fisher, R A Clift, Scott I. Bearman, Rainer Storb, Stephen W. Crawford, Jean E. Sanders and Clyde D. Ford and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Finn Bo Petersen

70 papers receiving 5.0k citations

Hit Papers

Regimen-related toxicity ... 1988 2026 2000 2013 1988 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Regimen-related toxicity in patients undergoing bone marrow transplantation.
    1988 717 citations CD Buckner, Finn Bo Petersen et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Finn Bo Petersen United States 33 2.9k 1.6k 1.2k 932 901 72 5.2k
Rafael F. Duarte Spain 39 3.3k 1.1× 1.8k 1.1× 1.3k 1.1× 1.0k 1.1× 963 1.1× 163 6.1k
M. Boogaerts Belgium 38 2.2k 0.7× 1.2k 0.7× 1.1k 1.0× 771 0.8× 1.1k 1.2× 102 4.8k
Liisa Volin Finland 45 4.6k 1.6× 1.8k 1.1× 1.3k 1.1× 1.2k 1.3× 709 0.8× 210 7.0k
Hisashi Sakamaki Japan 41 4.1k 1.4× 1.4k 0.9× 1.0k 0.9× 1.1k 1.2× 617 0.7× 304 6.4k
Antonio Pagliuca United Kingdom 43 3.2k 1.1× 1.2k 0.7× 870 0.7× 1.5k 1.6× 551 0.6× 207 5.5k
Rainer Schwerdtfeger Germany 43 4.3k 1.5× 1.4k 0.8× 860 0.7× 1.3k 1.4× 534 0.6× 126 6.0k
Anna Locasciulli Italy 45 3.4k 1.2× 1.5k 0.9× 1.4k 1.2× 1.0k 1.1× 452 0.5× 128 5.4k
Maria Teresa Van Lint Italy 47 4.7k 1.6× 1.7k 1.1× 1.0k 0.9× 1.5k 1.6× 624 0.7× 133 6.4k
Agnès Buzyn France 44 3.0k 1.0× 1.5k 0.9× 715 0.6× 1.0k 1.1× 483 0.5× 137 5.7k
Hartmut Link Germany 36 2.4k 0.8× 1.9k 1.2× 835 0.7× 501 0.5× 439 0.5× 142 5.1k

Countries citing papers authored by Finn Bo Petersen

Since Specialization
Citations

This map shows the geographic impact of Finn Bo Petersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Finn Bo Petersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Finn Bo Petersen more than expected).

Fields of papers citing papers by Finn Bo Petersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Finn Bo Petersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Finn Bo Petersen. The network helps show where Finn Bo Petersen may publish in the future.

Co-authorship network of co-authors of Finn Bo Petersen

This figure shows the co-authorship network connecting the top 25 collaborators of Finn Bo Petersen. A scholar is included among the top collaborators of Finn Bo Petersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Finn Bo Petersen. Finn Bo Petersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petersen, Finn Bo, et al.. (2017). In Copenhagen Libraries are Everywhere. Bibliotekovedenie [Russian Journal of Library Science]. 66(4). 429–434. 1 indexed citations
2.
Webb, Brandon, Michaela A. Gazdik, Bert K. Lopansri, et al.. (2017). Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation. Clinical Infectious Diseases. 64(12). 1753–1759. 35 indexed citations
3.
Ford, Clyde D., Michaela A. Gazdik, Bert K. Lopansri, et al.. (2016). Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes. Biology of Blood and Marrow Transplantation. 23(2). 340–346. 33 indexed citations
4.
Ford, Clyde D., Bert K. Lopansri, Michaela A. Gazdik, et al.. (2015). The clinical impact of vancomycin‐resistant E nterococcus colonization and bloodstream infection in patients undergoing autologous transplantation. Transplant Infectious Disease. 17(5). 688–694. 14 indexed citations
5.
6.
Kornblit, Brian, DG Maloney, Barry E. Storer, et al.. (2014). A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation. Haematologica. 99(10). 1624–1631. 28 indexed citations
7.
Giralt, Sergio, Luciano J. Costa, Jeffrey Schriber, et al.. (2013). Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations. Biology of Blood and Marrow Transplantation. 20(3). 295–308. 252 indexed citations
8.
9.
Hegenbart, Ute, Dietger Niederwieser, Brenda M. Sandmaier, et al.. (2005). Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors. Journal of Clinical Oncology. 24(3). 444–453. 181 indexed citations
10.
Ford, Clyde D., et al.. (2004). Effect of prior chemotherapy on hematopoietic stem cell mobilization. Bone Marrow Transplantation. 33(9). 901–905. 43 indexed citations
11.
12.
Maertens, J., Issam Raad, G. Petrikkos, et al.. (2004). Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy. Clinical Infectious Diseases. 39(11). 1563–1571. 465 indexed citations
13.
Ford, Clyde D., et al.. (2003). An evaluation of predictive factors for CD34+ cell harvest yields from patients mobilized with chemotherapy and growth factors. Transfusion. 43(5). 622–625. 31 indexed citations
14.
Nash, Richard A., Joseph H. Antin, Chatchada Karanes, et al.. (2000). Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.. PubMed. 96(6). 2062–8. 426 indexed citations
15.
Jørgensen, Jorunn B., et al.. (1997). Does Old Age Contraindicate TURP. European Urology. 31(3). 281–285. 10 indexed citations
16.
Demirer, Taner, Charles H. Weaver, CD Buckner, et al.. (1995). High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy.. Journal of Clinical Oncology. 13(3). 596–602. 71 indexed citations
17.
Hackman, Robert C., David K. Madtes, Finn Bo Petersen, & Joan G. Clark. (1989). PULMONARY VENOOCCLUSIVE DISEASE FOLLOWING BONE MARROW TRANSPLANTATION1. Transplantation. 47(6). 989–992. 73 indexed citations
18.
Crawford, Stephen W., David A. Schwartz, Finn Bo Petersen, & Joan G. Clark. (1988). Mechanical Ventilation after Marrow Transplantation: Risk Factors and Clinical Outcome. American Review of Respiratory Disease. 137(3). 682–687. 94 indexed citations
19.
Henriksen, Lars Onsberg, et al.. (1988). The effect of intravesically administered cetiprin on bladder spasms after transurethral resection of the prostate. International Urology and Nephrology. 20(5). 497–500.
20.
Hill, Roger S., Gil Segal, Finn Bo Petersen, et al.. (1987). Preparation of red-blood-cell-depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processor.. PubMed. 15(1). 93–8. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rafael F. Duarte Breakdown of academic impact, for papers by M. Boogaerts Breakdown of academic impact, for papers by Liisa Volin Breakdown of academic impact, for papers by Hisashi Sakamaki Breakdown of academic impact, for papers by Antonio Pagliuca Breakdown of academic impact, for papers by Rainer Schwerdtfeger Breakdown of academic impact, for papers by Anna Locasciulli Breakdown of academic impact, for papers by Maria Teresa Van Lint Breakdown of academic impact, for papers by Agnès Buzyn Breakdown of academic impact, for papers by Hartmut Link
Rankless by CCL
2026